Literature DB >> 21859430

Clonal and lineage analysis of somatic DNMT3A and JAK2 mutations in a chronic phase polycythemia vera patient.

Nisha Rao, Carolyn M Butcher, Ian D Lewis, David M Ross, Junia V Melo, Hamish S Scott, Peter G Bardy, Richard J D'Andrea.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21859430     DOI： 10.1111/j.1365-2141.2011.08837.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  Whole-exome sequencing of polycythemia vera revealed novel driver genes and somatic mutation shared by T cells and granulocytes.

Authors:  L Wang; S I Swierczek; J Drummond; K Hickman; S J Kim; K Walker; H Doddapaneni; D M Muzny; R A Gibbs; D A Wheeler; J T Prchal
Journal:  Leukemia       Date:  2014-01-13       Impact factor: 11.528

2.  DNMT3A mutation analysis in adult patients with acute lymphoblastic leukemia.

Authors:  Ya-Nan Liu; Na Zhang; Ying Wu; Li Yang; Xiao-Yi Ding; Jian-Feng Zhou; Min Xiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

Review 3.  Genetic Background of Polycythemia Vera.

Authors:  Mathilde Regimbeau; Romain Mary; François Hermetet; François Girodon
Journal:  Genes (Basel)       Date:  2022-04-02       Impact factor: 4.141

4.  Screening for mutation R882 in the DNMT3A gene in Chinese patients with hematological disease.

Authors:  Yunlong Li; Deng-Feng Zhang; Shi-Wen Zhang; Yun Zeng; Yong-Gang Yao
Journal:  Int J Hematol       Date:  2012-06-29       Impact factor: 2.490

5.  DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia.

Authors:  Preetesh Jain; Srdan Verstovsek; Wei Wang; Sanam Loghavi; Harrys A Torres; Zeev Estrov; Keyur P Patel; Naveen Pemmaraju
Journal:  Leuk Lymphoma       Date:  2015-12-24

6.  DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype.

Authors:  Jyoti Nangalia; Francesca L Nice; David C Wedge; Anna L Godfrey; Jacob Grinfeld; Clare Thakker; Charlie E Massie; Joanna Baxter; David Sewell; Yvonne Silber; Peter J Campbell; Anthony R Green
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

7.  Molecular genetics of myelofibrosis and its associated disease phenotypes.

Authors:  Ali Tabarroki; Ramon V Tiu
Journal:  Transl Med UniSa       Date:  2014-02-04

8.  Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses.

Authors:  Trine Alma Knudsen; Vibe Skov; Kristen Stevenson; Lillian Werner; William Duke; Charles Laurore; Christopher J Gibson; Anwesha Nag; Aaron R Thorner; Bruce Wollison; Dennis Lund Hansen; Christina Ellervik; Daniel El Fassi; Karin de Stricker; Lukas Frans Ocias; Mette Brabrand; Ole Weis Bjerrum; Ulrik Malthe Overgaard; Mikael Frederiksen; Thomas Kielsgaard Kristensen; Torben A Kruse; Mads Thomassen; Torben Mourits-Andersen; Marianne Tang Severinsen; Jesper Stentoft; Joern Starklint; Donna S Neuberg; Lasse Kjaer; Thomas Stauffer Larsen; Hans Carl Hasselbalch; R Coleman Lindsley; Ann Mullally
Journal:  Blood Adv       Date:  2022-04-12

Review 9.  The Molecular Genetics of Myeloproliferative Neoplasms.

Authors:  Anna E Marneth; Ann Mullally
Journal:  Cold Spring Harb Perspect Med       Date:  2020-02-03       Impact factor: 6.915
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.